Health Trials

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

ConditionsMyomaSurgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorThe University of Texas Health Science Center, Houston

About this trial

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Eligibility criteria

Qualifiers

Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/>5cm or

Patients undergoing minimally invasive Myomectomy with =/> 5 fibroids

Disqualifiers

Pregnancy,

Age <18yo,

Patients undergoing concomitant surgery such as endometriosis surgery,

Suspected malignancy

Trial design

Treatments tested in this trial

  • Temporary clamping of uterine and ovarian vessels

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

Source ClinicalTrials.gov